News

Eli Lilly posts strong Q1 results, but weight-loss drug sales disappoint
Eli Lilly on Thursday posted better-than-expected first quarter revenue and profit, although sales of its popular weight-loss ...
Eli Lilly CEO waves off CVS-Novo Nordisk deal: 'It feels a little like last decade'
But Eli Lilly CEO David Ricks waved off the deal Thursday, telling Yahoo Finance in an interview that the company is focused ...
Why Eli Lilly Stock Is Sinking Today
Shares of Eli Lilly ( LLY -10.79%) are sliding on Thursday. The stock lost 8.3% as of 12:21 p.m. ET. The leg down comes as ...
Eli Lilly Beats Q1 Profit Estimates on Strength of Diabetes Drug
FILE PHOTO: Vials of Eli Lilly's Mounjaro, a tirzepatide injection drug used for treating type 2 diabetes and weight loss, ...
Why Eli Lilly (LLY) Stock Is Nosediving
Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) fell 11% in the afternoon session after the company reported ...
Eli Lilly CEO says tariffs are not the answer, urges Trump to move fast on trade deals
Eli Lilly CEO Dave Ricks took a stand against Trump's tariffs in a Q1 earnings call. The medicine company has strong operations for obesity and weight loss drugs in Ireland.
Stock Movers: Meta, Eli Lilly, Kohl's
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...
Eli Lilly's Stock Is Up 15% This Year, and Here's Why It Could Take Off Even More
Growth stocks often don't come cheap, especially when their prospects look great, as is the case with Eli Lilly ( LLY 1.09%).
Eli Lilly’s worst day in nearly 17 years: Strategist Jared Holz on Q1 results
Jared Holz, Mizuho Securities health care strategist, joins 'Fast Money' to discuss Eli Lilly's biggest day drop since 2008 ...
Stock Movers: Kohl's, Eli Lilly, Microsoft
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...